Bank of America’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-240,000
Closed -$2.09M 8676
2025
Q2
$2.09M Buy
+240,000
New +$1.74M ﹤0.01% 4739
2021
Q4
Sell
-10,000
Closed -$1.27M 8629
2021
Q3
$1.27M Sell
10,000
-18,300
-65% -$2.66M ﹤0.01% 4847
2021
Q2
$4.71M Sell
28,300
-68,700
-71% -$11.1M ﹤0.01% 3563
2021
Q1
$17.6M Buy
97,000
+75,900
+360% +$17.6M ﹤0.01% 2140
2020
Q4
$4.22M Buy
21,100
+20,500
+3,417% +$4.17M ﹤0.01% 3286
2020
Q3
$132K Buy
+600
New +$127K ﹤0.01% 5530
2020
Q1
Sell
-10,000
Closed -$837K 7235
2019
Q4
$837K Buy
+10,000
New +$761K ﹤0.01% 4630

Other funds holding TDOC

Bank of America's TDOC Position: Q1 2026 in Review

Bank of America increased its Teladoc Health (TDOC) stake by 290% in Q1 2026, buying an estimated $6.65M and bringing the position to 1,595,219 shares worth $8.69M. The position accounts for ﹤0.01% of the portfolio, ranked #3076.

Bank of America first reported a position in TDOC in Q3 2015 and has held it in 43 quarters since. The position peaked at $504M in Q3 2020. 323 funds tracked by Wall St. Rank hold TDOC as of Q1 2026.

  • Bank of America held 1,595,219 shares of Teladoc Health worth $8.69M as of Q1 2026.
  • Bank of America bought 1,186,042 Teladoc Health shares in Q1 2026, an estimated $6.65M.
  • Teladoc Health made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #3076 holding.
  • Bank of America first reported a position in Teladoc Health in Q3 2015 and has held it in 43 quarters since.
  • Bank of America's Teladoc Health position peaked at $504M in Q3 2020.
  • 323 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.